Replay available

BioArctic AB (BIOA_B) Q1 2026 Earnings Call

BioArctic AB (STO: BIOA_B) Q1 2026 earnings conference call, held 2026-05-20. Replay captured from the company's public earnings webcast.

Wed, May 20, 2026 at 1:00 AMendedReplay
BioArctic AB (BIOA_B) Q1 2026 Earnings Call

Hosted by

Featured presenters

Gennila Oswald

CEO at BIOAARTIK

Anders Macklin Lehert

CFO

Joanna Felting

Chief R and D Officer

Anna Kajagre and Blatt

Chief Commercial Officer

Joseph Hedden

Rx Securities

Suzanne Van Voorhausen

Kempen

Rajan Sharma

Goldman Sachs

Natalia Webster

RBC

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bioarctic Ab Class B.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04245-ea83-7573-ad85-fdfbf874d104 Created: 2026-08-27T08:11:16.546Z Duration: 2852.04 Channels: 1 00:00:00.000 -- 00:00:02.960 Good morning, and welcome to BIOATIQ's presentation for 00:00:02.960 -- 00:00:05.120 the first quarter of twenty twenty six. 00:00:05.680 -- 00:00:07.520 It has been a strong start of the 00:00:07.520 -- 00:00:10.719 year for BIOATIQ following a transformative year of 00:00:10.719 -- 00:00:11.679 2025 00:00:11.679 -- 00:00:13.519 with record financial results. 00:00:14.285 -- 00:00:16.685 It shows that the growth year at continuous 00:00:16.685 -- 00:00:18.605 in a great way for BIOAFIC. 00:00:19.485 -- 00:00:21.565 It's reassuring to see that more and more 00:00:21.565 -- 00:00:23.965 patients are getting access to the BIOAMEI. 00:00:24.365 -- 00:00:26.445 And we had more than 00:00:26.845 -- 00:00:28.605 €500,000,000 00:00:28.605 -- 00:00:29.485 of sales 00:00:29.770 -- 00:00:32.890 during our partner Eisai's fiscal year. 00:00:33.370 -- 00:00:36.090 And that resulted in a commercial milestone to 00:00:36.090 -- 00:00:36.970 BIOALPIC. 00:00:38.170 -- 00:00:41.690 Our projects and our brain transporter technology are 00:00:41.690 -- 00:00:43.210 also progressing really well. 00:00:43.885 -- 00:00:46.925 And we have increased focus on business development, 00:00:47.325 -- 00:00:48.365 which is based 00:00:48.685 -- 00:00:51.565 on great interest in brain transporter and in 00:00:51.565 -- 00:00:53.965 our projects. I'll talk more about that in 00:00:53.965 -- 00:00:55.245 today's presentation. 00:00:55.405 -- 00:00:56.365 Next slide, please. 00:00:58.880 -- 00:01:01.600 BIOAARTIK is listed at Nasdaq Stockholm Northcap, and 00:01:01.600 -- 00:01:03.760 this is our disclaimer. Next s...